相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Production of dengue virus-like particles serotype-3 in silkworm larvae and their ability to elicit a humoral immune response in mice
Doddy Irawan Setyo Utomo et al.
AMB EXPRESS (2020)
Agglutination of Human Polyomaviruses by Using a Tetravalent Glycocluster as a Cross-Linker
Makoto Ogata et al.
ACS OMEGA (2020)
Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus
Moritz U. G. Kraemer et al.
NATURE MICROBIOLOGY (2019)
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
S. Sridhar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
SWISS-MODEL: homology modelling of protein structures and complexes
Andrew Waterhouse et al.
NUCLEIC ACIDS RESEARCH (2018)
Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope
Stefan W. Metz et al.
VIROLOGY JOURNAL (2018)
Transcriptome changes induced by arbuscular mycorrhizal fungi in sunflower (Helianthus annuus L.) roots
Alberto Vangelisti et al.
SCIENTIFIC REPORTS (2018)
Dengue envelope-based 'four-in-one' virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice
Ravi Kant Rajpoot et al.
SCIENTIFIC REPORTS (2018)
A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice
Viswanathan Ramasamy et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo
Rahul Shukla et al.
FRONTIERS IN MICROBIOLOGY (2018)
Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature
Helene Boigard et al.
VACCINE (2018)
An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design
Akane Urakami et al.
JOURNAL OF VIROLOGY (2017)
Antibody-dependent enhancement of severe dengue disease in humans
Leah C. Katzelnick et al.
SCIENCE (2017)
Development of a Japanese encephalitis virus-like particle vaccine in silkworms using codon-optimised prM and envelope genes
Sayaka Matsuda et al.
HELIYON (2017)
Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus
Ryohei Saga et al.
SCIENTIFIC REPORTS (2016)
Recognition determinants of broadly neutralizing human antibodies against dengue viruses
Alexander Rouvinski et al.
NATURE (2015)
Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography
L. Huhti et al.
ARCHIVES OF VIROLOGY (2013)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Atomic-level functional model of dengue virus Envelope protein infectivity
Elizabeth A. Christian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Upasana Arora et al.
JOURNAL OF NANOBIOTECHNOLOGY (2012)
Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice
Shuo Zhang et al.
VIROLOGY JOURNAL (2011)
Crystal Structure of Dengue Virus Type 1 Envelope Protein in the Postfusion Conformation and Its Implications for Membrane Fusion
Vinod Nayak et al.
JOURNAL OF VIROLOGY (2009)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells
WD Crill et al.
JOURNAL OF VIROLOGY (2001)
分享论文
